Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naratriptan for Hostility and Aggression in Convicts
NCT00282165Phase 4Terminated
- Start
- Nov 2006
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in intermittent explosive disorder (IED) and impulse control disorder (ICD) comparing Naratriptan First with Placebo First (2 arms). Primary endpoints: Number of aggressive incidents at 10 weeks and Aggression scores (AVL and SDAS) at 10 weeks. Started Nov 2006; status: terminated.
02
Drugs
naratriptan
03
Conditions
intermittent explosive disorder (IED)impulse control disorder (ICD)
Beyond the preview
Go deeper on NCT00282165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00282165.